Royal Medicalink Pharma

PT Royal Medicalink Pharmalab is an Indonesian pharmaceutical company established in 2008 that specializes in the development and manufacturing of natural and herbal-based medicines. The company is a pioneer in the Indonesian herbal industry, notably producing VipAlbumin, the first snakehead fish (Channa striata) extract to receive the prestigious Fitofarmaka certification for treating hypoalbuminemia. Royal Medicalink Pharmalab integrates traditional Indonesian herbal wisdom with modern biotechnology and scientific research, collaborating with academic institutions like Universitas Gadjah Mada to develop innovative products such as local probiotics. Its portfolio includes a wide range of supplements for liver health, cholesterol management, and immune support, all manufactured under strict CPOTB (Good Manufacturing Practices for Traditional Medicines) and Halal standards.